Esperion Therapeutics Income Statement (2018-2025) | ESPR

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 145.42M0.98M0.98M0.98M1.84M212.24M3.83M9.64M7.98M40.66M14.41M15.40M18.84M18.84M18.98M18.82M24.33M25.79M33.97M32.25M137.74M73.83M51.63M69.11M65.00M82.39M87.31M
Cost of Revenue 0.03M0.40M0.28M1.69M1.78M1.80M5.56M5.08M7.12M9.18M6.51M4.16M11.65M6.79M13.38M11.45M10.07M15.61M17.29M25.63M31.54M28.54M41.29M
Gross Profit 1.81M211.84M3.56M7.95M6.19M38.86M8.85M10.33M11.71M9.66M12.47M14.66M12.68M19.00M20.59M20.80M127.66M58.23M34.35M43.48M33.46M53.84M46.02M
Operating items
Research & Development 41.55M49.47M46.31M42.79M48.28M38.23M34.70M34.99M35.28M41.96M27.95M25.07M25.33M27.62M24.32M32.43M29.14M33.03M31.38M22.10M14.88M17.74M13.40M11.46M10.40M10.98M12.56M7.24M14.13M
Selling, General & Administrative 9.01M11.18M12.18M13.49M18.47M21.71M41.55M47.68M48.83M61.55M61.06M46.32M39.27M38.34M30.38M29.61M24.95M24.14M29.90M33.96M33.24M45.42M41.99M44.19M39.98M36.92M43.00M39.51M41.85M
Other Operating Expenses 0.03M0.40M0.28M1.69M1.78M1.80M5.56M5.08M7.12M9.18M6.51M4.16M11.65M6.79M13.38M11.45M10.07M15.61M17.29M25.63M31.54M28.54M41.29M
Operating Expenses 50.56M60.65M58.49M56.28M66.75M59.95M76.29M83.07M84.38M105.21M90.80M73.19M70.15M71.03M61.83M71.22M60.60M61.33M72.93M62.84M61.50M74.62M65.47M71.25M67.66M73.53M87.09M75.29M97.27M
Operating Income -50.56M-60.65M86.93M-55.30M-65.77M-58.96M-74.45M129.17M-80.55M-95.57M-82.82M-32.53M-55.74M-55.63M-42.99M-52.38M-41.62M-42.51M-48.60M-37.06M-27.53M-42.37M72.27M2.58M-16.03M-4.42M-22.10M7.09M-9.96M
EBIT -50.56M-60.65M86.93M-55.30M-65.77M-58.96M-74.45M129.17M-80.55M-95.57M-82.82M-32.53M-55.74M-55.63M-42.99M-52.38M-41.62M-42.51M-48.60M-37.06M-27.53M-42.37M72.27M2.58M-16.03M-4.42M-22.10M7.09M-9.96M
Non-operating items
Other Non Operating Income 0.65M0.61M0.45M1.08M1.39M1.14M0.37M0.08M0.04M0.02M0.01M0.01M0.01M3.94M0.32M0.32M0.66M1.35M1.27M1.66M1.28M1.08M2.78M-53.23M1.58M-1.68M1.07M0.67M0.68M
Non Operating Income 0.65M0.61M0.45M1.08M1.39M1.14M0.37M0.08M0.04M0.02M0.01M0.01M0.01M3.94M0.32M0.32M0.66M1.35M1.27M1.66M1.28M1.08M2.78M2.45M1.58M1.21M1.07M0.67M0.68M
Net income details
EBT -50.56M-60.65M86.93M-55.30M-69.76M-63.09M-78.62M124.53M-85.48M-104.50M-90.95M-43.68M-69.40M-69.06M-57.05M-66.64M-55.78M-56.84M-62.99M-51.59M-42.53M-57.42M58.24M-11.14M-31.11M-20.84M-41.53M-13.39M-32.01M
Profit After Tax -49.91M-60.04M87.38M-54.22M-68.38M-61.95M-78.25M124.61M-85.44M-104.48M-90.94M-43.67M-69.39M-65.12M-56.73M-66.32M-55.12M-55.49M-61.72M-49.94M-41.25M-56.34M61.02M-61.92M-29.52M-21.32M-40.45M-12.72M-31.33M
Income from Continuing Operations -50.56M-60.65M86.93M-55.30M-69.76M-63.09M-78.62M124.53M-85.48M-104.50M-90.95M-43.68M-69.40M-69.06M-57.05M-66.64M-55.78M-56.84M-62.99M-51.59M-42.53M-57.42M58.24M-11.14M-31.11M-20.84M-41.53M-13.39M-32.01M
Consolidated Net Income -50.56M-60.65M86.93M-55.30M-69.76M-63.09M-78.62M124.53M-85.48M-104.50M-90.95M-43.68M-69.40M-69.06M-57.05M-66.64M-55.78M-56.84M-62.99M-51.59M-42.53M-57.42M58.24M-11.14M-31.11M-20.84M-41.53M-13.39M-32.01M
Income towards Parent Company -50.56M-60.65M86.93M-55.30M-69.76M-63.09M-78.62M124.53M-85.48M-104.50M-90.95M-43.68M-69.40M-69.06M-57.05M-66.64M-55.78M-56.84M-62.99M-51.59M-42.53M-57.42M58.24M-11.14M-31.11M-20.84M-41.53M-13.39M-32.01M
Net Income towards Common Stockholders -50.56M-60.65M86.93M-55.30M-69.76M-63.09M-78.62M124.53M-85.48M-104.50M-90.95M-43.68M-69.40M-69.06M-57.05M-66.64M-55.78M-56.84M-62.99M-51.59M-42.53M-57.42M58.24M-11.14M-31.11M-20.84M-41.53M-13.39M-32.01M
Additional items
EPS (Basic) -1.86-2.243.26-2.01-2.52-2.26-2.844.50-3.07-3.89-3.50-1.67-2.62-1.53-0.93-1.05-0.81-0.74-0.79-0.46-0.37-0.500.36-0.33-0.15-0.11-0.21-0.06-0.16
EPS (Weighted Average and Diluted) 3.07-2.01-2.33-2.844.32-3.07-3.82-3.50-1.67-2.62-1.53-0.93-1.05-0.81-0.74-0.79-0.46-0.37-0.500.34-0.33-0.15-0.11-0.21-0.06-0.16
Shares Outstanding (Weighted Average) 26.50M26.79M26.81M26.81M26.92M26.92M27.17M27.33M27.51M27.62M27.83M27.88M27.94M28.19M28.28M29.08M62.82M63.01M66.55M73.68M76.57M94.71M106.99M113.72M185.05M189.46M196.22M197.04M197.85M198.20M201.62M
Shares Outstanding (Diluted Average) 26.61M26.79M28.45M28.52M27.09M28.95M27.83M27.47M25.99M26.23M26.46M28.90M60.95M63.23M67.81M66.41M78.44M109.24M111.87M103.11M189.64M188.79M194.93M187.18M196.13M197.55M200.74M
EBITDA -49.70M-59.80M87.59M-54.13M-68.35M-61.93M-78.26M124.60M-85.44M-104.48M-90.94M-43.67M-69.39M-65.15M-56.96M-66.36M-54.91M-55.40M-61.72M-49.93M-41.25M-56.34M61.02M-61.92M-29.52M-21.32M-40.45M-12.72M-31.33M
Interest Expenses 4.00M4.12M4.17M4.64M4.93M8.93M8.12M11.14M13.65M13.43M14.06M14.27M14.15M14.33M14.39M14.54M14.99M15.06M14.02M13.72M15.08M16.42M19.43M20.49M22.05M